Endometriosis(EMs),characterized by the presence of endometrioid tissue outside the uterine cavity,is a common chronic benign recurrent disease in women of childbearing age,with a global incidence rate of about 10%.Due to its multifactorial nature and unclear pathogenesis,the current diagnostic gold standard for this dis-ease is still laparoscopic pathology.There is a lack of sensitive and specific biomarkers in clinical practice.Find-ing accurate,reliable,and applicable non-invasive biomarkers is currently a hot topic and focus of research.This article summarizes the most important and novel research results of EMs-related glycoproteins,transcriptomics,and autoantibody biomarkers,and provides new strategies for early diagnosis and targeted therapy.
维普
万方数据